CitraFlow™ 46.7% SF for vascular access device locking

CitraFlow™ 46.7% SF prefilled syringes are filled with an anticoagulant and antimicrobial 46.7% sodium citrate solution. CitraFlow™ 46.7% SF is a proven alternative to heparin to lock Vascular Access Devices. It avoids the risks associated with systemic heparinization and is safe for use in patients with suspected or confirmed Heparin Induced Thrombocytopenia.